A carregar...
Syk and tired of current chronic GVHD therapies
In this issue of Blood, Flynn et al(1) provide key data that lend further support to the development of clinical trials of spleen tyrosine kinase (Syk) inhibition for more effective chronic graft-versus-host disease (cGVHD) treatment.
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4481589/ https://ncbi.nlm.nih.gov/pubmed/26113534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-05-640672 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|